Lead optimization of apyrazolo[1,5-a]pyrimidin-7(4H)-one scaffold to identify potent, selective and orally bioavailable KDM5 inhibitors suitable for in vivo biological studies

被引：35

作者：

Liang, Jun ^{[1
]}

Zhang, Birong ^{[1
]}

Labadie, Sharada ^{[1
]}

Ortwine, Daniel F. ^{[1
]}

Vinogradova, Maia ^{[1
]}

Kiefer, James R. ^{[1
]}

Gehling, Victor S. ^{[2
]}

Harmange, Jean-Christophe ^{[2
]}

Cummings, Richard ^{[2
]}

Lai, Tommy ^{[3
]}

Liao, Jiangpeng ^{[3
]}

Zheng, Xiaoping ^{[3
]}

Liu, Yichin ^{[1
]}

Gustafson, Amy ^{[1
]}

Van der Porten, Erica ^{[1
]}

Mao, Weifeng ^{[3
]}

Liederer, Bianca M. ^{[1
]}

Deshmukh, Gauri ^{[1
]}

Classon, Marie ^{[1
]}

Trojer, Patrick ^{[2
]}

Dragovich, Peter S. ^{[1
]}

Murray, Lesley ^{[1
]}

机构：

[1] Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA

[2] Constellat Pharmaceut Inc, 215 First St,Suite 200, Cambridge, MA 02142 USA

[3] WuXi AppTec, 288 Fute Zhong Rd, Shanghai 200131, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2016年 / 26卷 / 16期

关键词：

Histone demethylase; KDM5; Selective KDM5 inhibitors; Epigenetics; Drug resistance; Lead optimization; CELL PENETRANT INHIBITORS; DEMETHYLASE INHIBITORS; LYSINE DEMETHYLASES; HISTONE; DERIVATIVES; METHYLATION; INHERITANCE; MECHANISMS; FAMILIES;

D O I：

10.1016/j.bmcl.2016.06.078

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Starting with a lead [1,5-a]pyrimidin-7(4H)-one-containing molecule (1), we generated potent, selective and orally bioavailable KDM5 inhibitors. Using structure- and property-based approaches, we designed 48 with improved cell potency (PC9 H3K4Me3 EC50 = 0.34 mu M). Furthermore, 48 maintained suitable physiochemical properties and displayed an excellent pharmacokinetic (PK) profile in mice. When dosed orally in mice at 50 mg/kg twice a day (BID), 48 showed an unbound maximal plasma concentration (C-max) >15-fold over its cell EC50, thereby providing a robust chemical probe for studying KDM5 biological functions in vivo. (C) 2016 Elsevier Ltd. All rights reserved.

引用

页码：4036 / 4041

页数：6

共 4 条

[1] Surrogating and redirection of pyrazolo[1,5-a]pyrimidin-7(4H)-one core, a novel class of potent and selective DPP-4 inhibitors
Deng, Xinxian
Shen, Jian
Zhu, Hui
Xiao, Jia
Sun, Ran
Xie, Fangzhou
Lam, Celine
Wang, Juntao
Qiao, Yixue
Tavallaie, Mojdeh S.
Hu, Yang
Due, Yi
Li, Jianqi
Fu, Lei
Jiang, Faqin
BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (04) : 903 - 912
[2] A synthesis of novel 5-methylsulfanylazolo[1,5-a]pyrimidin-7(4H)-ones and investigation of their chemical and cytotoxic properties
Lyapustin, Daniil N.
Fayzullina, Dilya F.
Marusich, Irina V.
Kotovskaya, Svetlana K.
Melekhin, Vsevolod V.
Tokhtueva, Maria D.
Ulomsky, Evgeny N.
Rusinov, Vladimir L.
CHEMISTRY OF HETEROCYCLIC COMPOUNDS, 2024, 60 (1-2) : 52 - 57
[3] Synthesis, photophysical properties and fluorescent application of novel [1,2,4]triazolo[1,5-a]pyrimidin-7(4H)-one derivatives
Gan, Suya
Gao, Li-Xin
Cao, Zitong
Zhang, Chun
Fu, Yiqiu
Wang, Wen-Long
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY, 2025, 464
[4] In vitro and in vivo antiparasital activity against Trypanosoma cruzi of three novel 5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one-based complexes
Caballero, Ana B.
Marin, Clotilde
Rodriguez-Dieguez, Antonio
Ramirez-Macias, Inmaculada
Barea, Elisa
Sanchez-Moreno, Manuel
Salas, Juan M.
JOURNAL OF INORGANIC BIOCHEMISTRY, 2011, 105 (06) : 770 - 776

← 1 →